Aminocaproic Acid: Clinical Trials

25 trials of Aminocaproic Acid, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

16 completed, 3 terminated, 2 unknown, 1 active not recruiting. 9 Phase 4, 5 Phase 2, 3 Not applicable, 2 Early Phase 1, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 49Completed 6, Not yet recruiting 1, Terminated 1, Unknown 1
Phase 25Completed 3, Active not recruiting 1, Terminated 1
Not applicable3Completed 2, Unknown 1
Early Phase 12Completed 1, Terminated 1
Phase 12Completed 1, Withdrawn 1
Phase 31Completed 1

Follow Aminocaproic Acid: new trials by email Literature Review of Aminocaproic Acid trials Research Report on Aminocaproic Acid

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
Bupivacaine, Lidocaine, Thrombin - Postoperative Pain
Phase 4Not yet recruitingNYU Langone Health402026-08-012026-06-12
Evaluating Postoperative Non-Opioid Pain Management Utilizing Local Anesthetics Coupled With Modulated Coagulation
Tranexamic acid, Aminocaproic acid, Recombinant Human Thrombin - Opioid Pain Medication
Phase 4TerminatedNYU Langone Health462021-03-242024-06-26
Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)
The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: - Coronavirus Infection (COVID-19), Pulmonary Arterial Hypertension
RecruitingDuke University50002020-03-052026-08-21
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss After Total Hip Replacement
Aminocaproic Acid 1000Mg Tab, Tranexamic acid tablets - Blood Loss, Surgical
Phase 2CompletedCarlos A Acosta-Olivo902020-02-062021-04-28
Oral Tranexamic Acid vs. Oral Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Knee Replacement.
Oral Tranexamic Acid, Oral Aminocaproic Acid - Knee Osteoarthritis, Blood Clot
Phase 2CompletedUniversidad Autonoma de Nuevo Leon922017-10-152019-07-30
Activated Factor Seven in Traumatic Retro Peritoneal Hematoma
ventilators, aminocaproic acid, Novo Seven - Traumatic Bleeding
CompletedKing Abdul Aziz Specialist Hospital802017-05-052020-06-11
Management of Intracerebral Hemorrhage With Aminocaproic Acid - Pilot Study
ɛ-Aminocaproic Acid - Intracerebral Hemorrhage
Phase 1WithdrawnThe University of Texas Health Science Center at San Antonio2016-06-012017-07-11
A Pilot Study Comparing Anti-Inflammatory Effects Of TXA Versus EACA In Pediatric Congenital Heart Surgery
Tranexamic acid, Epsilon Aminocaproic Acid - Pediatric Cardiac Surgery, Complication of Extracorporeal Circulation
Phase 4CompletedWake Forest University Health Sciences222016-02-012024-10-24
TXA vs. Amicar in Total Knee and Hip Arthroplasty
Amicar, TXA - Blood Loss, Hip Arthritis
Phase 4CompletedDuke University2462015-01-012018-12-05
Efficacy of Amicar for Children Having Craniofacial Surgery
Amicar (ε-aminocaproic acid), normal saline - Craniosynostosis
Phase 2Active not recruitingChildren's National Research Institute222014-10-012026-04-07
PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid)
EACA, Platelet transfusion - Hematological Malignancies, Thrombocytopenia
Phase 2TerminatedEmory University292014-05-232022-07-19
Clinical Efficacy of Tranexamic Acid and ε-Aminocaproic Acid in Reducing Blood Loss Following Total Knee Replacement
Tranexamic Acid (TXA), ε-Aminocaproic Acid (EACA) - Osteoarthritis
Phase 4CompletedMiller Orthopedic Specialists1942014-01-012016-03-21
Randomized Clinical Trial With Aminocaproic Acid in the Prevention of Exodontic Bleeding in Anticoagulants Patients
Aminocaproic acid, Routine dental care, lidocaine and epinephrine - Oral Hemorrhage
Phase 4UnknownGrupo de Estudos Multicentricos em Onco-Hematologia1542013-12-012014-09-12
Fibrinolysis Before Cardiopulmonary Bypass?
Epsilonaminocaproic acid, Placebo - Pathologic Fibrinolysis
Phase 4CompletedStanford University402013-07-012016-06-30
Dosing of Amicar and Measure of Fibrinolysis by TEG During Cardiac Surgery
epsilon-aminocaproic acid (EACA) - Aortic Disease
Early Phase 1TerminatedUniversity of Pennsylvania82013-01-012019-05-02
Epsilon Aminocaproic Acid Vs. Tranexamic Acid Vs. Placebo for Prevention of Blood Loss in Total Knee Arthroplasty
Tranexamic Acid, Epsilon Aminocaproic Acid, Normal Saline - Osteoarthritis
Not applicableUnknownHeekin Orthopedic Research Institute542012-04-012016-07-26
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
The POPS study is collecting PK data on children prescribed the following drugs of interest per standard of care: - Adenovirus, Anesthesia
CompletedDaniel Benjamin35202011-11-012023-09-06
Effects of Aminocaproic Acid (ACA) on Rosacea-specific Inflammation
Topical aminocaproic acid (ACA) mixed with Vanicream, Vehicle cream - Rosacea
Early Phase 1CompletedUniversity of California, San Diego152011-07-012019-09-13
Comparison of Tranexamic to Epsilon Aminocaproic Acid: a Prospective Analysis of Blood Conservation in Cardiac Surgery
Tranexamic Acid, Aminocaproic Acid - Cardiopulmonary Bypass
Not applicableCompletedLoma Linda University1002010-03-012020-10-19
Amicar Pharmacokinetics of Children Having Craniofacial Surgery
Epsilon-Aminocaproic Acid - Craniosynostosis
Phase 1CompletedPaul Stricker182009-05-012012-11-01

Showing 20 of 25. Sign in to see all of them.

Conditions studied

Hemorrhage (5)  ·  Arrhythmias, Cardiac (2)  ·  Craniosynostoses (2)  ·  Heart Failure (2)  ·  Hemophilia A (2)  ·  Hyperaldosteronism (2)  ·  Hypertension (2)  ·  Hypokalemia (2)  ·  Inflammation (2)  ·  Menorrhagia (2)  ·  Osteoarthritis (2)  ·  Pain (2)  ·  Pneumonia (2)  ·  Pulmonary Arterial Hypertension (2)  ·  Scoliosis (2)

Sponsors

NYU Langone Health (3)  ·  Duke University (2)  ·  Carlos A Acosta-Olivo (1)  ·  Children's National Research Institute (1)  ·  Daniel Benjamin (1)  ·  Emory University (1)  ·  Grupo de Estudos Multicentricos em Onco-Hematologia (1)  ·  Heekin Orthopedic Research Institute (1)  ·  King Abdul Aziz Specialist Hospital (1)  ·  Loma Linda University (1)  ·  Miller Orthopedic Specialists (1)  ·  National Heart, Lung, and Blood Institute (NHLBI) (1)  ·  Paul Stricker (1)  ·  Stanford University (1)  ·  State University of New York - Upstate Medical University (1)

Countries

United States (19)  ·  Canada (2)  ·  Mexico (2)  ·  Brazil (1)  ·  Israel (1)  ·  Saudi Arabia (1)  ·  Singapore (1)  ·  United Kingdom (1)

Top investigators

David Chiu, MD (2)  ·  Ana G. Antun, MD, MSc (1)  ·  Andrew VanBergen, M.D. (1)  ·  Baron S Lonner, MD (1)  ·  Carlos Acosta-Olivo, PhD (1)  ·  Chi Hornik (1)  ·  Chi Hornik, PharmD (1)  ·  Clifford K Boese, MD (1)  ·  Felix Vilchez-Cavazos, MD PhD (1)  ·  Jason Gatling, MD (1)  ·  Jean-Louis Caron, MD, FRCS(C) (1)  ·  Mias Pretorius, MBChB (1)  ·  Nancy A Nussmeier, MD (1)  ·  Paul Stricker, MD (1)  ·  Peter L Bailey, MD' (1)

Results publications

PMID 16531440, PMID 19730217, PMID 20370916, PMID 21600028, PMID 23361105, PMID 23955184, PMID 24614374, PMID 24949994, PMID 26039810, PMID 26926644, PMID 27522443, PMID 27699724, PMID 28137820, PMID 28244907, PMID 28290120, PMID 28779462, PMID 28939033, PMID 28968480, PMID 28976426, PMID 29084742, PMID 29107495, PMID 29271816, PMID 29435949, PMID 29677389, PMID 29723672, PMID 30790601, PMID 31317556, PMID 31491796, PMID 31548185, PMID 31814149, PMID 32324313, PMID 32497307, PMID 33029806, PMID 33903114, PMID 34302290, PMID 35370711, PMID 35491971, PMID 41247430, PMID 4195730

NIH funding

K23HL070058 (1)